Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 2 (3), 419-27

The Use of Isotopes in the Determination of Absolute Bioavailability of Drugs in Humans

Affiliations
Review

The Use of Isotopes in the Determination of Absolute Bioavailability of Drugs in Humans

Graham Lappin et al. Expert Opin Drug Metab Toxicol.

Abstract

Absolute bioavailability studies in humans are not routinely performed as part of the drug registration process. They tend to be reasonably demanding, not least because toxicology data are required to support intravenous administration of a drug. Moreover, the classical crossover design of an absolute bioavailability study can suffer from artefacts caused by concentration-dependent pharmacokinetics. Many of the problems associated with absolute bioavailability studies can be alleviated using isotopically labelled drugs. Stable isotopes have been used in the performance of absolute bioavailability studies in humans for > 30 years. More recently, the advantages of using radiolabelled drugs have been expanded by using the ultrasensitive technology of accelerator mass spectrometry. Isotopic labelling not only allows for the accurate and efficient determination of absolute bioavailability, but can also provide information on first-pass effects and other pharmacokinetic parameters.

Similar articles

See all similar articles

Cited by 12 articles

See all "Cited by" articles

MeSH terms

LinkOut - more resources

Feedback